Cita APA (7a ed.)

M, S., & G, S. (2011). Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: Patient and cost-effectiveness considerations. Dove Medical Press.

Cita Chicago Style (17a ed.)

M, Scolnik, y Singh G. Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-effectiveness Considerations. Dove Medical Press, 2011.

Cita MLA (8a ed.)

M, Scolnik, y Singh G. Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-effectiveness Considerations. Dove Medical Press, 2011.